HMGB1 and chronic kidney disease: Furthermore, recently investigated biomarkers of mortality, such as free light chains (FLCs) or serum high mobility group box 1 (HMGB1), may serve as important parameters that reflect inflammation and immune dysfunction in CKD and AKI patients [34,35].